A blood test based on whole-genome sequencing achieved 99% sensitivity and specificity for detecting HPV-positive head and neck cancer. Early postoperative detection of circulating tumor DNA predicted ...

In the U.S., lower HPV vaccination rates, uneven access to screening and delayed adoption of HPV-based testing have contributed to preventable illness and death. These are not inevitable outcomes; ...

While the method shows promise, some experts say that other self-collection devices are more readily available ...

Testing menstrual blood for human papillomavirus (HPV) could be a "robust alternative or replacement" for current cervical ...

One of the first tests that allows patients to self-collect samples to screen for human papillomavirus (HPV) will soon be available in doctors' offices. In May, the U.S. Food and Drug Administration ...

However, the test for antibodies against HPV16 E6 is not suitable for assessing the risk for cervical cancer and other HPV-associated cancers in genital areas. As opposed to cancer of the oropharynx, ...

By Dr. Liji Thomas, MD A simple menstrual pad may offer a scalable, non-invasive way to expand cervical cancer screening, ...

Women who have been vaccinated against human papillomavirus (HPV) should be screened for cervical cancer less often, a study has suggested.1 For women vaccinated at young ages, screening just two or ...